3136 results for «762»

Filter By

3136 results

Outcomes of TAVI devices

21 Nov 2021 – From PCR London Valves 2021

This PCR London Valves 2021 session on TAVI compiles the results of various clinical studies conducted on different valve models on the market today and in the future: J-valve, Acurate Neo-2, Perimount P 2900, and many others.

Outcomes of TAVI devices

Closing TAVI with next generation suture mediated closure device

21 Nov 2021 – From PCR London Valves 2021

Join Francesco Maisano to learn more about about the Perclose ProStyle, a next generation closure device for TAVI procedures, and discover some interesting tips & tricks.

Closing TAVI with next

New 2021 ESC heart failure and valvular heart diseases guidelines : impact on secondary mitral regurgitation management

21 Nov 2021 – From PCR London Valves 2021

Join Ralph Stephan Von Bardeleben and Marco Metra if you want to learn about the new ESC 2021 guidelines in heart failure management and the key interconnections between the heart failure and the valvular heart diseases guidelines, as well as to understand how this will improve...

New 2021 ESC heart failure

TAVI valve and implantation technique: the secrets for optimising outcomes

21 Nov 2021 – From PCR London Valves 2021

Join Neil Moat, Helge Möllmann, Lars Søndergaard and Ganesh Manoharan to hear the experience of an account achieve single digit permanent pacemaker implantation, to learn how to preserve coronary access for future patients' treatment, and to see how new product features can reduce paravalvular leak.

TAVI valve and implantation

The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in clinical practice

21 Nov 2021 – From PCR London Valves 2021

Join Raúl Moreno, Julian Widder and Mathias Wolfrum  if you want to learn about a single-centre experience of their first 100 patients treated with the ALLEGRA, and to see clinical outcome data on over 250 cases treated with ALLEGRA from a European multicentre registry.

The uncompromised hemodynamics

Is image fusion needed or too complex for standard transcatheter edge-to-edge repair?

21 Nov 2021 – From PCR London Valves 2021

Join Covadonga Fernandez-Golfin, Roberto Corti and Patric Biaggi if you want to learn about the benefits of image fusion and discover some tips and tricks on how to make image fusion easy and not complex in transcatheter edge-to-edge-repair.

Is image fusion needed

TAVI procedural improvements

21 Nov 2021 – From PCR London Valves 2021

Train on the cusp overlap method for self-expanding TAVR, get acquainted with override pacing to stabilize self-expandable TAVI valve, know more about atrioventricular conduction recovery and predictors of pacemakerr dependency after TAVI, among others, in this PCR London Valves 2021 session.

TAVI procedural improvements

TAVI pathways

21 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session, look at logistics and outcomes of TAVI during the COVID-19 pandemic, be presented with a simple risk-stratification tool based on a pre-procedural multimarker approach in TAVI, study duration of hospitalisation in patients with complicated transcatheter aortic valve implantation, and...

TAVI pathways

Lean TAVI: safe efficiencies and better economics

21 Nov 2021 – From PCR London Valves 2021

Join Dider Tchétché and Stefan Toggweiler if you want to learn about the Lean TAVI practice and the Lucerne study results, the Lean TAVI adoption at other centres / Heart Teams, as well as the procedural efficiencies and their importance in the success of the overall...

Lean TAVI: safe efficiencies

TAVI procedure planning and optimising patient outcomes

21 Nov 2021 – From PCR London Valves 2021

Watch this series of videos from PCR London Valves 2021 to evaluate whether TAVICT scans can replace invasive coronary angiography pre-TAVI, to appreciate how pre-operative computed tomography evaluation of aortic burden can predict acute kidney injury post-TAVR, and to appraise mortality in TAVI patients converted to...

TAVI procedure planning and optimising patient outcomes

Outcomes after novel transcatheter and surgical tricuspid valve interventions

21 Nov 2021 – From PCR London Valves 2021

Find out more about TRI-SCORE, a new risk score to predict in-hospital mortality after isolated tricuspid valve surgery, 30-day outcomes for transcatheter tricuspid repair from the TriBAND study, both the CLASP TR early feasibility and TRISCEND studies six-month results, and more in this PCR London Valves...

Outcomes after novel transcatheter and surgical tricuspid valve interventions

Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis

21 Nov 2021 – From PCR London Valves 2021

Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.

Predictability at release

EAPCI: patient initiatives around the world

22 Nov 2021 – From PCR London Valves 2021

In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.

EAPCI:  patient initiatives around the world

Leading clinical evidence while disrupting the mitral paradigm with clip therapy

17 May 2022 – From EuroPCR 2022

Watch this EuroPCR 2022 session with Nicole Karam, Stephan Baldus, Fabien Praz, Wolfgang Rottbauer, and Martin Swaans, and learn how the recent guidelines change the game in mitral disease management, how they can be implemented in practice, and what are the latest real-life clip data and...

Leading clinical evidence while disrupting the mitral paradigm with clip therapy

Advances in renal denervation: from patient selection to procedure

17 May 2022 – From EuroPCR 2022

For this EuroPCR 2022 session, Felix Mahfoud is joined by David Kandzari, Rasha Al-Lamee, Flavio Ribichini, and Andrew Sharp to talk about renal denervation: hear real-life experiences and get the latest preclinical and clinical data on the long-term safety and efficacy of the radiofrequency renal denervation...

Advances in renal denervation: from patient selection to procedure

Valve-in-valve: the journey starts with the first prosthesis

17 May 2022 – From EuroPCR 2022

In this EuroPCR 2022 session featuring Philip Maccarthy, Julia Mascherbauer, Hendrik Treede, Christian Hengstenberg, Radoslaw Parma, and Giuseppe Tarantini, analyze the impact of valve-in-valve interventions on lifetime management, learn about particular clinical considerations and the procedural technique of TAVI-in-TAVI procedures, and appreciate the potential pitfalls of...

Valve-in-valve: the journey starts with the first prosthesis

The cathlab of the future

17 May 2022 – From EuroPCR 2022

Let's take the practical case of an 84-year-old male patient with hypertension, dyslipidaemia, and severe aortic stenosis: in this EuroPCR 2022 session, find out how to treat such a patient in the cathlab of the future and discuss the benefits of non-invasive technology at tableside, tools...

The cathlab of the future

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation

Towards a personalised coronary intervention with CT-guided robotic-assisted PCI

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session aims to show how coronary CT angiography can help in pre-procedural planning and guidance of PCI to achieve the best patient outcomes. It also explores the role of robotic-assisted PCI in improving procedural accuracy, radiation safety, and ergonomics within the cathlab. Finally, it demonstrates how...

Towards a personalised coronary intervention with CT-guided robotic-assisted PCI

Start treating refractory angina patients with Reducer therapy - Practical aspects

17 May 2022 – From EuroPCR 2022

Looking at a 75-year-old male patient with HTA, diabetes, and hypothyroidism, a history of coronary artery disease treated with PCI of the RCA, and a previous coronary angiography showing preserved LVEF and in-stent restenosis of the RCA, you will learn in this EuroPCR 2022 session how...

Start treating refractory angina patients with Reducer therapy - Practical aspects
Didn’t find what you were looking for?